Russia: Sputnik V vaccine 92 percent effective

0
Alexander Gintsburg, director of the Gamaleya National Research Center for Epidemiology and Microbiology, shows bottles with Sputnik-V vaccine against the coronavirus disease (COVID-19) during an interview with Reuters in Moscow, Russia September 24, 2020. Picture taken September 24, 2020. REUTERS/Tatyana Makeyeva

The race between countries in the corona vaccine is heating up. After the announcement that the Pfizer / BioNTech vaccine achieved a success rate of 90 percent, the statement “Sputnik V vaccine was 92 percent successful” came from Russia.

The race between Russia and the West over the corona virus vaccine is heating up. A similar announcement came from Russia after the announcement that the vaccine developed by the American pharmaceutical company Pfizer and Germany-based BioNTech achieved a 90 percent success rate in the third phase trials. It was announced that the success rate of the Russian vaccine Sputnik V in the third phase trials was 92 percent.

FIRST DATA FROM THE TEST ON 16 THOUSAND PEOPLE

In the statement of the Russian Direct Investment Fund, which finances and markets the Russian vaccine, the details of the interim test results of the third phase trials of Sputnik V were shared with the public. Accordingly, 92 percent success was achieved in the first Phase-3 trials of two-dose Sputnik V on 16 thousand people. In the statement, it was stated that subjects who took two doses of Sputnik V in the trials were 92 percent less likely to get Covid-19 than subjects who were given placebo.

‘THEY WILL TELL TO THE TORUNS ONE DAY’

“Based on the data, we show that we have a very effective vaccine,” said Kirill Dmitriev, head of the Russian Direct Investment Fund. Dmitriev said this was a very important piece of news, “the kind that the people who developed the vaccine will tell their grandchildren one day”.

TOTAL WILL BE TESTED ON 40 THOUSAND PEOPLE

Phase-3 trials of the Sputnik V vaccine developed by the Gamaleya Institute are carried out in 29 clinics in Moscow. It is stated that a total of 40 thousand volunteers will participate in the trials, and a quarter of these people will receive a placebo.

See Also
Tension of Fishing Boats Between Russia North Korea

REGISTERED BEFORE PHASE-3 TRIALS

Sputnik V, Russia’s vaccine, is the first corona vaccine to be registered in the world. However, the registration of the vaccine before the completion of Phase-3 tests, which means large-scale trials on humans, attracted the Western world.


LEAVE A REPLY

Please enter your comment!
Please enter your name here